Skip to main content
PLOS One logoLink to PLOS One
. 2026 Apr 6;21(4):e0345457. doi: 10.1371/journal.pone.0345457

Clinical profile and hospital outcomes of children with Down syndrome diagnosed with congenital heart disease in a developing country: A retrospective study

Zawadi Edward Kalezi 1,2,*, Jimmy France Mchalange 1, Naizihijwa Gadi Majani 1,2, Alphonce Nsabi Simbila 3,4, Vivienne Aiyana Mlawi 1, Deogratias Arnold Nkya 1,2, Peter Richard Kisenge 1
Editor: Palesa Motshabi Chakane5
PMCID: PMC13052895  PMID: 41941515

Abstract

Background

The World health organization (WHO) identifies Down syndrome (DS) as one among common congenital disorders, along with congenital heart defects. Approximately fifty percent of children diagnosed with DS are affected by congenital heart defects which significantly impact their survival. Nevertheless, in low and middle income countries, there is limited published data on congenital heart defects in children with DS and their treatment outcomes. Therefore, this study aimed to document the clinical characteristics and hospital outcomes of children with DS who were diagnosed with heart defects. The goal is to assist healthcare providers and policymakers in improving care for these children.

Methods

This was a retrospective descriptive study of children with DS diagnosed with heart disease admitted at the Jakaya Kikwete Cardiac Institute (JKCI) from December 2022 through December 2024. Socio-demographics, clinical characteristics, and survival data were extracted from medical records. Frequencies and proportions were calculated for categorical variables. The description of mean with standard deviation (SD) and median with and interquartile range (IQR) were calculated for continuous data. For the missing data, the case deletion approach was used.

Results

In two years, out of 1,356 admitted children, data from 104 children with Down syndrome were analysed. Most of them, 93.2%, were aged below 5 years, with a slight predominance of male children, of almost 58%. Fifty percent (58/104) of study participants resided in the coastal region of Tanzania, followed by the northern zone (19.2%, 20/104). The most frequent cardiac diagnoses were AVSD, 46.2% and VSD, 14.4% with a median age at diagnosis of 5 months (IQR, 3.3–10). The median age of the mothers was 38 years (IQR, 38–42) while the mean age of the fathers was 36.9 years (SD, ± 7.1). At discharge, nearly a quarter, 19.2% of children had prolonged hospital stays of more than 2 weeks, and 7.7% (8/104) of enrolled children died. Nevertheless, 4.8% of children with Down syndrome underwent open cardiac surgery during the study period.

Conclusion

Advanced maternal age, paternal age and AVSD were frequently observed in this study, nevertheless; a significant number of the enrolled children were first diagnosed beyond 5 months of age. Hence, the study recommends early screening echocardiography among children with Down syndrome and more studies with a large sample size to evaluate long-term outcomes in this population.

Background

Down syndrome (DS) is one of the most common chromosomal disorders with an incidence of approximately 1 in 733 live births [1]. A population-based study in the USA, estimated the live birth prevalence for DS to be approximately 12.6 per 10,000 (1 in 792) in the era of DS-related elective pregnancy terminations [2]. Despite limited studies in developing countries, the prevalence of DS is reported to be higher compared to developed settings. However, this is contrary to what was reported in the 1990s. This could be attributable to many factors including advanced maternal age at birth, elective DS-related pregnancy terminations following prenatal diagnosis, and traditional beliefs [3,4].

Advanced maternal age remains the primary risk factor of having a child with trisomy 21; however, the younger women with higher overall birth rates also increase the risk of DS [1]. Furthermore, age below 20 years and above 40 years has been mentioned to increase the likelihood of chromosomal and non-chromosomal abnormalities. A nine-year cross-sectional survey was conducted after a few studies reported a shift to younger maternal age for DS in the Rwandan population. Conversely, this study found that the mean maternal age at birth of DS was significantly higher compared to the general population [5].

Down syndrome is reported to be associated with congenital anomalies, in addition to cognitive impairment. Around 50% of the children with DS are more prone to have congenital heart defects (CHD) [1,6]. This includes atrioventricular septal defect (AVSD) which has been reported to be the most common type of CHD among the DS population. However, recent studies have shown that the ventricular septal defect (VSD) is also a frequently reported lesion [6,7]. A Tanzanian single-centre study screened 3982 children identified 1371 to have CHD, and the most common associated syndrome was DS accounting for 12.8% of all recruited children [8].

The life expectancy of children with DS is lower compared with the non-DS population [1]. This finding is attributed to presence of the CHD, and other comorbidities like leukaemia and seizures. The presence of CHD in these children leads to recurrent respiratory infections, congestive heart failure and pulmonary hypertension (PHT). Nevertheless, children with DS have a propensity to develop persistent PHT and irreversible pulmonary vascular disease earlier than in non-DS children. Thus, early repair of heart defect in the first year of life has been recommended to minimize the risks of heart failure, and irreversible pulmonary vascular disease [1,9].

CHD is one among the major predictors of survival in children with DS, however, documentation on its burden and related outcomes is limited in developing settings. We, therefore, conducted this study to demonstrate the clinical profile and hospital outcomes of children with Down syndrome in the hope of aiding healthcare workers and policy makers regarding the care of this special group of children.

Methods

Study design and setting

This was a hospital-based retrospective descriptive study conducted among DS children with CHD admitted at the Jakaya Kikwete Cardiac Institute (JKCI) from December 2022 through December 2024. JKCI is a 150-bed capacity national referral and teaching centre located in Dar es Salaam, Tanzania. It provides specialized cardiac services including percutaneous interventions and open cardiac surgery for both children and adults.

Study population and participants

All DS children with CHD aged 1 month to 18 years admitted to the paediatric unit during the study period were enrolled. However, participants with incomplete data and those readmitted were excluded during chart review. The patient data were accessed for research purposes from 23rd June 2025.

Study variables

Medical records of all children with DS at JKCI within 2 years were reviewed. Clinical and sociodemographic parameters were age, gender, paternal age, maternal age, parity, address (residence), date of admission and discharge, history of cardiac surgery/ cardiac catheterization, laboratory findings, documented cardiac and non-cardiac diagnoses, age at cardiac diagnosis and survival (death/ alive) at discharge.

Data management and analysis

Data entry and cleaning were done using Statistical Package for Social Science (SPSS) version 25. The description of mean with standard deviation (SD) and median with and interquartile range (IQR) were calculated for continuous normally distributed and skewed data respectively. Frequencies and proportions were calculated for categorical variables. For the missing data, the case deletion approach was used.

Ethical consideration

Ethical approval to conduct the study was obtained from the Ethics Review Committee of the Jakaya Kikwete Cardiac Institute with ethical clearance number AB.123/307/01K/39. All the data were anonymized to ensure patient confidentiality and being retrospective study an informed written consent from each study participant was not needed per ethical committee.

Results

Over a two-year period, a total of 1,356 children were admitted to the JKCI. Of these, 165 children had DS. Thirty-four children had missing information, and 27 children who were readmitted were excluded. Therefore, 104 study participants were included in the final analysis (Fig 1).

Fig 1. Flow diagram of study participants and outcomes.

Fig 1

Over a two-year period, 1,356 children were admitted to the JKCI. Of these, 165 children had DS. Thirty-four children had missing information and 27 readmitted children were excluded. A total of 104 participants were included in the final analysis.

As shown in Table 1, Out of 104 children with DS, most of them, 93.2%, were aged below 5 years with a slight predominance of male children of almost 58%. The median child’s position in the family was 3 (IQR, 2–5) and the majority (75/104) were in third position and above. Fifty percent (58/104) of study participants were residing in the coastal region of Tanzania, followed by the northern zone (19.2%, 20/104). The most frequent cardiac diagnoses were AVSD, 46.2% and VSD, 14.4% with a median age at diagnosis of 5 months (IQR, 3.3–10). Other documented diagnoses were heart failure (44%), pneumonia (24%), and sepsis (23%). The median age of the mothers was 38 years (IQR, 38–42) while the mean age of the fathers was 36.9 (SD, ± 7.1).

Table 1. Demographic and clinical characteristics of children with Down syndrome admitted at JKCI in Tanzania, 2023-2024 (N = 104).

Variable Category Frequency (%)
Age (yr) < 1 54 (51.9)
1- < 5 43 (41.3)
5- < 10 6 (5.8)
10-18 1 (1.0)
Gender Male 60 (57.7)
Place of residence Coastal/ Eastern zone 58 (55.8)
Northern zone 20 (19.2)
Lake zone 9 (8.7)
Western zone 3 (2.9)
Central zone 2 (1.9)
Southern highlands 6 (5.8)
Southern zone 6 (5.8)
Parity ≤ 2 29 (27.9)
> 2 75 (72.1)
Median (IQR) 3 (2–5)
Maternal age Median (IQR) 38 (33-42)
Paternal age Mean ± SD 36.9 ± 7.1
Anaemia Yes 65 (62.5)
Non severe 61 (58.7)
Severe 4 (3.8)
Underlying cardiac diagnosis VSD 15 (14.4)
AVSD 48 (46.2)
PDA 7 (6.7)
ASD 7 (6.7)
TOF 8 (7.7)
Multiple defects 17 (16.3)
Structurally Normal heart 2 (1.9)
Age at the time of cardiac diagnosis Median (IQR) 5 (3.3-10)
Other diagnoses Heart failure 46 (44.2)
Pneumonia 25 (24)
Sepsis 24 (23.1)
Others 9 (8.7)

At discharge, nearly a quarter of the children (19.2%) had prolonged hospital stays of more than two weeks, and 7.7% (8/104) of enrolled children died (Fig 2). Nevertheless, only 4.8% of children with DS underwent open cardiac surgery during the study period.

Fig 2. Hospital outcomes at discharge among enrolled children.

Fig 2

A total of 19.2% of children had prolonged hospital stays of more than two weeks, 7.7% (8/104) died, and 4.8% of children with Down syndrome (DS) underwent open cardiac surgery during the study period.

Discussion

This study determined the clinical profile and hospital outcomes of the children with Down syndrome admitted at JKCI from December 2022 through December 2024. In 2 years, 165 children with Down syndrome were admitted, however, only 104 children were included in the final analysis due to missing information and readmissions. AVSD and VSD were the most frequent cardiac lesions diagnosed beyond 5 months of age in half of the study participants. The present study indicates that half of the mothers were aged 38 years and above while the average fathers’ age was 36.9 years. Nevertheless 4.8% of the children with Down syndrome underwent open cardiac surgery and only eight children died out of 104 enrolled children.

In this study, almost half of the children had AVSD, which is comparable to other previous studies [1,8,10]. However, recent studies conducted in Malaysia and Egypt reported VSD being the commonest cardiac lesion among the DS cohort of children [6,7]. This variability of the cardiac lesions could be due to genetic variation, since both studies are from the Asian population.

Cardiac defects such as AVSD and other CHD with increased pulmonary blood flow need to have early surgical repair to minimize the risk of developing irreversible pulmonary vascular diseases, especially in children with DS [1]. However, in the present study, we observed more than half of children were first diagnosed with CHD later than 5 months of age. This fact increases the odds of these children, either having delayed surgical repair or not fit for surgical intervention, particularly in low-resource settings. There are several reasons for late surgical repair in developing countries, considering the pathway of care, one being diagnosed at an advanced age plus a long waiting surgical list. Nevertheless, in two years, 4.8% of the children with Down syndrome underwent cardiac surgeries.

Advanced maternal age has been reported consistently over the years to be a risk for having a child with DS [1,10]. This study also demonstrates that half of the mothers of these children were aged 38 years and above. Additionally, we observed that the average age of the fathers was 36.88 years. Whether it is advanced or not, to my knowledge, there are limited studies discussing further the paternal age to be a risk factor for DS. Some studies reported the influence of paternal age on DS, however, it is in association with advanced maternal age [1113].

We also observed that half of studied children were residing in the coastal region of Tanzania, encompassing five regions including Dar es Salaam. This finding could possibly be the proximity of these areas to our centre; however, this opens up a way for further studies regarding this observation.

This study had some limitations, including being retrospective, and secondly, the small number of study participants, which limited further statistical analysis.

Conclusion

Down syndrome is the most common syndrome among children with congenital heart disease, and advanced maternal age, and AVSD were frequently observed in this study. Furthermore, half of the enrolled children were first diagnosed at 5 months of age or above. Hence, this study recommends early screening echocardiography among children with Down syndrome during outpatient clinics and further studies with a large sample size to evaluate long-term outcomes in this population.

Supporting information

S1 File. Strobe checklist-Down syndrome.

(DOCX)

pone.0345457.s001.docx (22KB, docx)

Acknowledgments

We are grateful to all doctors and nurses who were involved in these patients.

Abbreviations

AVSD

Atrioventricular septal defect

CHD

Congenital heart disease

DS

Down syndrome

ECHO

Echocardiography

ICU

Intensive care unit

PDA

Patent ductus arteriosus

TOF

Tetralogy of Fallot

VSD

Ventricular septal defect.

Data Availability

All relevant data are within the paper.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Kliegman RM, Stanton BF, St Geme JW. Nelson Textbook of Pediatrics. 20 ed. 2015. [Google Scholar]
  • 2.de Graaf G, Buckley F, Skotko BG. Estimates of the live births, natural losses, and elective terminations with Down syndrome in the United States. Am J Med Genet A. 2015;167A(4):756–67. doi: 10.1002/ajmg.a.37001 [DOI] [PubMed] [Google Scholar]
  • 3.Christianson AL. Down syndrome in sub-Saharan Africa. J Med Genet. 1996;33(2):89–92. doi: 10.1136/jmg.33.2.89 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Oloyede O. Down syndrome in Nigeria Sub Saharan Africa, prenatal diagnosis and screening for Down syndrome. InTechopen. 2011. p. 166–96. [Google Scholar]
  • 5.Hitayezu JVN, Murorunkwere S, Ndinkabandi J, Uwineza ALM. Advanced maternal age, also an important risk factor for Down syndrome in African black population. A nine-year experience in Rwanda and burden outcome. Statew Agric L Use Baseline. 2015;1(0):1–26. [Google Scholar]
  • 6.Zahari N, Mat Bah MN, A Razak H, Thong M-K. Ten-year trend in prevalence and outcome of Down syndrome with congenital heart disease in a middle-income country. Eur J Pediatr. 2019;178(8):1267–74. doi: 10.1007/s00431-019-03403-x [DOI] [PubMed] [Google Scholar]
  • 7.El-Gilany A-H, Yahia S, Wahba Y. Prevalence of congenital heart diseases in children with Down syndrome in Mansoura, Egypt: a retrospective descriptive study. Ann Saudi Med. 2017;37(5):386–92. doi: 10.5144/0256-4947.2017.386 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Zuechner A, Mhada T, Majani NG, Sharau GG, Mahalu W, Freund MW. Spectrum of heart diseases in children presenting to a paediatric cardiac echocardiography clinic in the Lake Zone of Tanzania: a 7 years overview. 2019;4:4–9. [DOI] [PMC free article] [PubMed]
  • 9.McGlinchey E, Fortea J, Vava B, Andrews Y, Ranchod K, Kleinhans A. Raising awareness and addressing inequities for people with Down syndrome in South Africa. Int J Equity Health. 2025;24(1):7. doi: 10.1186/s12939-024-02349-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Allen HD, Shaddy RE, Penny DJ, Feltes TF, Cetta F. Heart disease in infants, children and adolescents. 2016. [Google Scholar]
  • 11.Fisch H, Hyun G, Golden R, Hensle TW, Olsson CA, Liberson GL. The influence of paternal age on down syndrome. J Urol. 2003;169(6):2275–8. doi: 10.1097/01.ju.0000067958.36077.d8 [DOI] [PubMed] [Google Scholar]
  • 12.Dzurova D, Pikhart H. Down syndrome, paternal age and education: comparison of California and the Czech Republic. BMC Public Health. 2005;5:69. doi: 10.1186/1471-2458-5-69 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Sotonica M, Mackic-Djurovic M, Hasic S, Kiseljakovic E, Jadric R, Ibrulj S. Association of Parental Age and the Type of Down Syndrome on the Territory of Bosnia and Herzegovina. Med Arch. 2016;70(2):88–91. doi: 10.5455/medarh.2016.70.88-91 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Palesa Motshabi Chakane

18 Dec 2025

Dear Dr. Kazeni

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Feb 01 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

• A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

• A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

• An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols....

We look forward to receiving your revised manuscript.

Kind regards,

Palesa Motshabi Chakane, PhD

Academic Editor

PLOS One

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include a separate caption for each figure in your manuscript.

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Additional Editor Comments:

Major Revision rlated to data presented. In text.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: No

**********

Reviewer #1: The outline of the aim and objectives is poorly worded.

The presentation of the data is adequate in the results and the discussion section but the abstract is poorly outlined.

There are colloquialisms involved in the discussion that are unnecessary e.g "at the other end of the pyramid"

Why are the mothers' ages described in median and the fathers in mean format.

There could be more referencing in the discussion portions, there are many assertions that appear to be congruent but they could be strengthened by seeking references.

The references are Vancouver style but there are at least 5 references that are in the incorrect format.

The Ethics clearance is current but it is not clear when it was initially sought. Is the ethics certificate an extension or only sought when the manuscript was submitted. In short, is ethics not sought before conduct of the research?

**********

what does this mean?). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy..-->

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

PLoS One. 2026 Apr 6;21(4):e0345457. doi: 10.1371/journal.pone.0345457.r002

Author response to Decision Letter 1


21 Jan 2026

Yes, we have reviewed the comments and the response to editor and reviewers have been attached, thank you

Attachment

Submitted filename: RESPONSE TO REVIEWERS-DOWN SYNDROME.docx

pone.0345457.s003.docx (17.9KB, docx)

Decision Letter 1

Palesa Motshabi Chakane

3 Feb 2026

Dear Dr. Kalezi,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 20 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

• A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

• A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

• An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols....

We look forward to receiving your revised manuscript.

Kind regards,

Palesa Motshabi Chakane, PhD

Academic Editor

PLOS One

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Additional Editor Comments:

Dear Authors

The authors opined that "The goal is to assist healthcare providers and policymakers in improving care for these children.", however, there are no lessons to be drawn from this study. There is very limited data and result in just one table. There was no attempt to find any associations or inferrences to the outcomes reported. The Authors are therefore adviced to enhance the manuscript by

1. Reporting on echocardiographic detasils of cardiac lesions if any

2. Risk factors of adverse outcome

3. Further edit the manuscript fior consistency in reporting as shoen in the abstract

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

PLoS One. 2026 Apr 6;21(4):e0345457. doi: 10.1371/journal.pone.0345457.r004

Author response to Decision Letter 2


19 Feb 2026

I have addresed the editors comments and attached the documents as suggested, thank you

Attachment

Submitted filename: RESPONSE TO EDITORS COMMENTS.docx

pone.0345457.s004.docx (18.2KB, docx)

Decision Letter 2

Palesa Motshabi Chakane

5 Mar 2026

CLINICAL PROFILE AND HOSPITAL OUTCOMES OF CHILDREN WITH DOWN SYNDROME DIAGNOSED WITH CONGENITAL HEART DISEASE IN A DEVELOPING COUNTRY. A RETROSPECTIVE STUDY

PONE-D-25-46314R2

Dear Dr. Kalezi,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support....

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Palesa Motshabi Chakane, PhD

Academic Editor

PLOS One

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Palesa Motshabi Chakane

PONE-D-25-46314R2

PLOS One

Dear Dr. Kalezi,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Palesa Motshabi Chakane

Academic Editor

PLOS One

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Strobe checklist-Down syndrome.

    (DOCX)

    pone.0345457.s001.docx (22KB, docx)
    Attachment

    Submitted filename: RESPONSE TO REVIEWERS-DOWN SYNDROME.docx

    pone.0345457.s003.docx (17.9KB, docx)
    Attachment

    Submitted filename: RESPONSE TO EDITORS COMMENTS.docx

    pone.0345457.s004.docx (18.2KB, docx)

    Data Availability Statement

    All relevant data are within the paper.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES